1424941-91-2

Basic information

• Product Name: C₂₂H₃₃N₃O₆Si
• Synonyms: C₂₂H₃₃N₃O₆Si
• CAS NO: 1424941-91-2
• Molecular Weight: 463.606
• Mol File: 1424941-91-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: C₂₂H₃₃N₃O₆Si(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₂H₃₃N₃O₆Si(1424941-91-2)
• EPA Substance Registry System: C₂₂H₃₃N₃O₆Si(1424941-91-2)

Safety Data

• Hazardous Substances Data: 1424941-91-2(Hazardous Substances Data)

Upstream product

• 22027-96-9 5-nitroveratral 
• 1424941-90-1 C₁₃H₂₆N₂O₂Si 
• 946658-23-7 2-((tert-butyldimethylsilyl)oxy)-N-ethylethan-1-amine 
• 18162-48-6 tert-butyldimethylsilyl chloride 

Downstream Products

• 1424941-93-4 C₁₆H₁₈ClN₃O₅ 
• 1424941-94-5 C₂₄H₃₁N₃O₇S₂ 
• 1424941-88-7 C₂₂H₂₇N₃O₇S₂ 
• 1424941-95-6 C₃₆H₄₇N₃O₇ 
• 1424941-89-8 C₃₄H₄₃N₃O₇ 

Relevant articles and documents

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE

The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of Parkinson's disease may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be also used for the treatment of Huntington's disease, Alzheimer's disease, Multiple Sclerosis, Lateral Sclerosis, Neural Motor disorders.

COMPOSITIONS AND METHODS FOR TREATMENT OF PARKINSON'S DISEASE

Provided are compounds, pharmaceutical acceptable salts, polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising the compounds may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral admimstration, syrup or injection, and may be used for the treatment of Parkinson's disease, Huntington's disease, Alzheimer's disease multiple sclerosis lateral sclerosis and neural motor disorders.